GKFF
VRTX icon

George Kaiser Family Foundation’s Vertex Pharmaceuticals VRTX Stock Holding History

George Kaiser Family Foundation’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$306K Sell
616
-253
-29% -$112K 0.03% 85
2026
Q1 		$388K Hold
869
– – 0.04% 52
2025
Q4 		$394K Hold
869
– – 0.05% 55
2025
Q3 		$340K Hold
869
– – 0.05% 64
2025
Q2 		$387K Buy
869
+272
+46% +$125K 0.06% 62
2025
Q1 		$289K Buy
+597
New +$278K 0.04% 33

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

George Kaiser Family Foundation's VRTX Position: Q2 2026 in Review

George Kaiser Family Foundation reduced its Vertex Pharmaceuticals (VRTX) stake by 29% in Q2 2026, selling an estimated $112K and leaving 616 shares worth $306K. The position accounts for 0.03% of the portfolio, ranked #85.

George Kaiser Family Foundation first reported a position in VRTX in Q1 2025 and has held it in 6 quarters since. The position peaked at $394K in Q4 2025. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • George Kaiser Family Foundation held 616 shares of Vertex Pharmaceuticals worth $306K as of Q2 2026.
  • George Kaiser Family Foundation sold 253 Vertex Pharmaceuticals shares in Q2 2026, an estimated $112K.
  • Vertex Pharmaceuticals made up 0.03% of George Kaiser Family Foundation's portfolio in Q2 2026, its #85 holding.
  • George Kaiser Family Foundation first reported a position in Vertex Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • George Kaiser Family Foundation's Vertex Pharmaceuticals position peaked at $394K in Q4 2025.
  • 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on George Kaiser Family Foundation's 13F filing for Q2 2026, filed 12 Aug 2026.